Tectonic Therapeutic | AVRO - Debt



Tectonic Therapeutic reported $1.11M in Debt for its fiscal quarter ending in June of 2024.

Debt Change Date
Adcock Ingram Holdings ZAR 480.07M 155.03M Dec/2023
Alnylam Pharmaceuticals USD 1.02B 280.04M Sep/2024
Celltrion KRW 2.2T 26.33B Sep/2024
Cspc Pharmaceutical CNY 388.87M 318.03M Jun/2024
Dianthus Therapeutics USD 0 407K Sep/2024
Ecofibre AUD 25.21M 1.83M Dec/2023
Gilead Sciences USD 23.35B 1.84B Jun/2024
Ionis Pharmaceuticals USD 1.28B 164.95M Sep/2024
Kangmei Pharma CNY 215.93M 40.04M Sep/2024
Knight Therapeutics CAD 70.09M 1M Mar/2024
Laboratorios Farma EUR 121.16M 39.38M Jun/2024
MacroGenics USD 0 34.06M Sep/2024
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 2.43M 134K Dec/2023
Neuren Pharmaceuticals AUD 0 0 Dec/2021
Organigram Holdings CAD 100K 18K Jun/2024
Pfizer USD 67.7B 976M Sep/2024
Pharma Mar EUR 53.07M 13.68M Sep/2024
Qiagen NV USD 1.92B 518.22M Sep/2024
Roche Holding CHF 34.44B 5.23B Jun/2024
Sanofi 23.75B 5.33B Jun/2024
Sarepta Therapeutics USD 1.23B 142.36M Sep/2024
Sartorius EUR 4.53B 98.7M Sep/2024
Sino Biopharmaceutical CNY 9.68B 2.9B Jun/2024
Takeda JPY 5.05T 429.79B Sep/2024
Tilray USD 388.42M 1.1M Aug/2024
Zz Pientze Pharmaceu 1.18B 28.21M Sep/2024